Comparison · NCT03860818-5451000a
Intervention Arm vs Control Arm: Patient Survival- Percentage of Patients That Died During Study
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Intervention Arm vs Control Arm: Patient Survival- Percentage of Patients That Died During Study. Trial comparisons, record NCT03860818-5451000a. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03860818-5451000a
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.15 | 0.132 | 0.17 | wilson | |
| Risk in group 2 | 0.161 | 0.138 | 0.186 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0107 | -0.0421 | 0.0198 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.933 | 0.766 | 1.14 | log | |
| Odds ratio, group 1 over group 2 | 0.922 | 0.729 | 1.17 | log | |
| Number needed to treat, for one fewer participant with the outcome on Intervention Arm than on Control Arm | 93.3 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: control.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Intervention Arm | Patients received the technology-enabled pharmacist intervention in addition to the usual standard of care. The intervention consisted of increased review of patients by a pharmacist and increased scrutiny of patients' medication regimens and laboratory values using a dashboard surveillance system. | 195 | 1,300 | OG001 |
| Group 2 | Control Arm | No intervention. Patients received standard usual care, which generally included the following: nurse coordinators or midlevel practitioners were responsible for general solid organ transplantation (SOT) patient oversight, including ensuring laboratory assessments were scheduled/reviewed and medication regimens were accurate and up to date. For usual care, pharmacists typically were consultants and were only involved in direct patient care if an issue arose, and the nurse or provider engaged the pharmacist for assistance. Within usual follow-up care, pharmacists did not conduct routine daily surveillance of SOT patients. | 144 | 896 | OG000 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Patient Survival- Percentage of Patients That Died During Study
- Description
Estimated patient survival rates, compared between the intervention and usual care groups and defined as the proportion of patients alive at the end of the 27-month study. Number of patients who died during the study (March 2019 - June 2021), Scientific Registry of Transplant Recipients (SRTR) or VA reported.
- Time frame
- 27-months
- Population
Source ClinicalTrials.gov
Trial
- Title
- Improving Transplant Medication Safety Through A Technology and Pharmacist Intervention
- NCT number
- NCT03860818
- Phases
- NA
- Conditions
- Transplant
- Interventions
- Health services delivery
- Lead sponsor
- VA Office of Research and Development
- Results first posted
- 2024-08-01
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT03860818?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT03860818-5451000a